Zobrazeno 1 - 10
of 357
pro vyhledávání: '"Bühring Hj"'
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 195 (2006)
Abstract Background The chemokine stromal derived factor-1 (SDF-1 or CXCL12) and its receptor CXCR4 have been demonstrated to be crucial for the homing of stem cells and prostate cancers to the marrow. While screening prostate cancers for CXCL12-resp
Externí odkaz:
https://doaj.org/article/ca26b8cc03a54f10bb2f6ca53014d659
Autor:
Ayline Kübler, Bühring Hj, Leibold Js, Ludger Grosse-Hovest, Kousis Pc, Gundram Jung, Sebastian P. Haen, Maya C. André, Helmut R. Salih, Samuel Koerner, Marina Pal
Publikováno v:
Leukemia. 31(2)
Antibody-dependent cellular cytotoxicity (ADCC) of natural killer (NK) cells largely contributes to the success of monoclonal antibody (mAb) treatment in cancer. As no antibodies are clinically available for immunotherapy of myeloid leukemias (MLs),
Autor:
Maximilian Bamberg, Nübling T, Elwira Pyz, Ludger Große-Hovest, Martin Hofmann, Hans-Georg Rammensee, Steffen Aulwurm, Sebastian P. Haen, Bühring Hj, Gundram Jung, Helmut R. Salih, Schwartz K, Karin Schilbach
Publikováno v:
Leukemia. 26:1228-1237
The therapeutic efficacy of humanized or chimeric second-generation antitumor antibodies is clearly established, but often limited. In recent years, defined modifications of the glycosylation pattern or the amino-acid sequence of the human immunoglob
Autor:
Carmelo Bernabeu, Ainhoa Letamendia, Shant Kumar, Bühring Hj, Ulla Raab, Pedro Lastres, Nuria Almendro
Publikováno v:
International Journal of Cancer. 76:541-546
Endoglin is an integral membrane glycoprotein that binds transforming growth factor-beta1 (TGF-beta1) with high affinity and it is strongly expressed on syncytiotrophoblasts throughout pregnancy. Here, we describe the expression of endoglin by the ch
Autor:
F. U. Weiss, Bahija Jallal, F. W. Busch, W.-D. Ludwig, Bühring Hj, H.-D. Waller, Axel Ullrich, I. Sures, Rupert Handgretinger
Publikováno v:
Blood. 86:1916-1923
The class I receptor tyrosine kinase (RTK) HER2 is an oncoprotein that is frequently involved in the pathogenesis of tumors of epithelial origin. Here we report mRNA expression in peripheral blood and bone marrow cells from healthy donors in hematopo
Autor:
Sylvie St Jacques, Bühring Hj, Jan A. van Mourik, Michelle Letarte, Carmelo Bernabeu, Philip J. O'Connell, Adonna Greaves, Anthony J. F. D'apice, Anne Gougos
Publikováno v:
International Immunology. 4:83-92
Endoglin is a glycoprotein expressed predominantly on human endothelial cells. It was first identified with mAb 44G4, produced against the pre-B acute lymphoblastic HOON cell line. We now report that four mAbs independently produced against human umb
Autor:
Schäfer, R., Dominici, M., Müller, I., Horwitz, E., Asahara, T., Bulte, Jwm, Bieback, K., Blanc, K Le, Bühring, Hj, Capogrossi, Mc, Dazzi, F., Gorodetsky, R., Henschler, R., Handgretinger, R., Kajstura, J., Kluger, Pj, Lange, C., Luettichau, I von, Mertsching, H., Schrezenmeier, H., Sievert, Kd, Strunk, D., Verfaillie, C., Northoff, H.
Publikováno v:
In Cytotherapy 2009 11(2):245-255
Publikováno v:
Acta haematologica. 96(3)
Interleukin 6 (IL6) secretion by blast cells derived from peripheral blood of patients with acute myelogenous leukemia (AML) was characterized. IL6 secretion showed a wide variation both when AML blasts were cultured in medium alone and in the presen
Autor:
Medi Adibzadeh, Graham Pawelec, Elke Schlotz, Thomas Daikeler, Kurt Schaudt, Petra Siegels-Hübenthal, Arnika Rehbein, Heike Pohla, Bühring Hj, A. Schenk, M. Owsianowsky
Publikováno v:
Cellular immunology. 154(1)
To enrich low-density human bone marrow (BM) cells for putative progenitors of T-lymphocytes, CD7+ CD3- cells were sorted (purity was estimated at > 99.9%) and cultured under limiting dilution conditions with irradiated allogeneic stimulator cells, i
Autor:
Bühring Hj, H.J. Lenz, G. Ehninger, E. Schneider, U. Schwuléra, G. Pawelec, Kurt Schaudt, H. Schlag
Publikováno v:
Cytokines in Hemopoiesis, Oncology, and AIDS ISBN: 9783540522812
Experience of the use of interleukin-2 (IL-2) to treat cancer patients has been almost exclusively based on trials with recombinant (nonglycosylated) lymphokine. Cell line (JURKAT)-derived IL-2 has been used clinically in a limited way, without drama
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c69a4c3e45ff97cea8a37f42da0bb12
https://doi.org/10.1007/978-3-642-75510-1_94
https://doi.org/10.1007/978-3-642-75510-1_94